Study finds technology may cost-effectively prevent neurovascular injuries and revision surgery.
Powered exoskeletons reclassified from class I to class II.
Micron will be sole producer of NEO's orthopedic implant designs.
AdvaMed leadership discusses states' efforts to alleviate the tax's pressure and details findings from the group's latest report.
First, in collaboration with LifeNet Health